易明医药
(002826)
| 流通市值：32.49亿 | | | 总市值：33.54亿 |
| 流通股本：1.85亿 | | | 总股本：1.91亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 359,623,665.2 | 182,577,229.06 | 636,272,038.57 | 488,983,972.66 |
| 营业总成本 | 305,912,646.03 | 157,841,477.13 | 573,356,762.17 | 435,575,357.61 |
| 其他经营收益 | | | | |
| 营业利润 | 83,057,547.65 | 24,880,525.1 | 100,612,923.19 | 89,326,733.14 |
| 利润总额 | 83,017,139.09 | 24,908,506.84 | 113,670,507.43 | 102,218,285.93 |
| 净利润 | 66,679,694.56 | 19,648,370.41 | 93,124,133.45 | 81,763,271.44 |
| 每股收益 | | | | |
| 其他综合收益 | -938,922.36 | -653,642.24 | -1,071,743.36 | -561,524.46 |
| 综合收益总额 | 65,740,772.2 | 18,994,728.17 | 92,052,390.09 | 81,201,746.98 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 790,670,109.65 | 723,274,292.79 | 633,682,261.96 | 672,277,976.29 |
| 非流动资产: | | | | |
| 非流动资产合计 | 405,854,608.43 | 380,016,559.21 | 383,992,112.77 | 386,495,583.84 |
| 资产总计 | 1,196,524,718.08 | 1,103,290,852 | 1,017,674,374.73 | 1,058,773,560.13 |
| 流动负债: | | | | |
| 流动负债合计 | 328,227,199.94 | 260,459,447.88 | 196,680,793.61 | 251,455,276.58 |
| 非流动负债: | | | | |
| 非流动负债合计 | 4,652,310.03 | 4,811,175.48 | 4,970,040.93 | 5,171,406.09 |
| 负债合计 | 332,879,509.97 | 265,270,623.36 | 201,650,834.54 | 256,626,682.67 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 863,645,208.11 | 838,020,228.64 | 816,023,540.19 | 802,146,877.46 |
| 股东权益合计 | 863,645,208.11 | 838,020,228.64 | 816,023,540.19 | 802,146,877.46 |
| 负债和股东权益合计 | 1,196,524,718.08 | 1,103,290,852 | 1,017,674,374.73 | 1,058,773,560.13 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 444,530,423.73 | 214,869,585.51 | 781,780,088.72 | 600,000,709.14 |
| 经营活动现金流出小计 | 270,574,482.14 | 135,499,804.51 | 658,059,922.93 | 450,402,714.31 |
| 经营活动产生的现金流量净额 | 173,955,941.59 | 79,369,781 | 123,720,165.79 | 149,597,994.83 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 881,961,874.79 | 200,401,833.34 | 720,659,041.13 | 435,779,715.98 |
| 投资活动现金流出小计 | 1,111,459,740.24 | 400,818,138.91 | 722,495,636.16 | 719,509,804.62 |
| 投资活动产生的现金流量净额 | -229,497,865.45 | -200,416,305.57 | -1,836,595.03 | -283,730,088.64 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 57,444,000 | 28,644,000 | 46,618,171.39 | 46,618,171.39 |
| 筹资活动现金流出小计 | 39,772,203.9 | 11,286,653.67 | 57,501,048.82 | 41,813,730.22 |
| 筹资活动产生的现金流量净额 | 17,671,796.1 | 17,357,346.33 | -10,882,877.43 | 4,804,441.17 |
| 汇率变动对现金及现金等价物的影响 | -457,296.9 | -418,483.11 | -734,015.58 | -387,406.55 |
| 现金及现金等价物净增加额 | -38,327,424.66 | -104,107,661.35 | 110,266,677.75 | -129,715,059.19 |
| 期末现金及现金等价物余额 | 499,337,390.47 | 433,557,153.78 | 537,664,815.13 | 297,683,078.19 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -38,327,424.66 | - | 110,266,677.75 | - |